Sarcoma
Conditions
Brief summary
The main aim of the study is evaluate quality of life and motor performance of patients with soft tissue sarcomas undergoing surgical treatment and post-operative rehabilitation treatment. Primary objectives: * Identification of clinical characteristics and motor damage after surgery for soft tissue sarcomas; * Impact of perioperative treatments and surgery on the quality of life of patients with soft tissue sarcomas; * Impact of post-operative rehabilitation treatment on quality of life and recovery of motor activity The primary endpoint will be the improvement in the Toronto Extremity Salvage Score (TESS) between T1 (post-surgery) and T3 (at the end of rehabilitation treatment). Secondary endpoints will be: 1\. the evolution over the various timepoints of the selected rating scales (Toronto Extremity Salvage Score, Musculoskeletal Tumor Society Rating Scale, Numerical Rating Scale, Brief Pain Questionnaire, Douleur Neuropathique en 4 Questions, Leeds Assessment of Neuropathic Symptoms and Signs Scale, European Organization for Research and Treatment of Cancer, Quality-of-Life Questionnaire (QLQ)-C30, Short Form Health Survey 36); • The change in walking performance before and after the rehabilitation treatment.
Interventions
Quality of life survey and motor performace survey
Sponsors
Study design
Eligibility
Inclusion criteria
\- Adult patients affected by primary localized soft tissue sarcoma, candidate to limb/trunk surgery with wide excision or retroperitoneal resection (including resection of the iliopsoas muscle with possible damage to the femoral nerve) with curative intent.
Exclusion criteria
* Patients with recurrent tumors; * patients with metastatic disease; * patients with palliative surgery; * patients with amputations.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in the Toronto Extremity Salvage Score (TESS) | T0 (1 week before surgery) T1 (1 week post-surgery) and T3 (3 months post-surgery) | a change in the TESS greater than 7 points |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain evaluation | T0 (1 week before surgery) T1 (1 week post-surgery) and T3 (3 months post-surgery) | Brief Pain Questionnaire |
| Motor performance evaluation | T0 (1 week before surgery) T1 (1 week post-surgery) and T3 (3 months post-surgery) | Musculoskeletal Tumor Society Rating Scale |
| Evaluation of Quality of Life | T0 (1 week before surgery) T1 (1 week post-surgery) and T3 (3 months post-surgery) | Quality-of-Life Questionnaire (QLQ)-C30 |
Countries
Italy